Edwards Lifesciences (EW) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Edwards Lifesciences (EW) PT Lowered to $118 at Barclays on 3Q; 'Quarter Over Quarter Slowdown in U.S. TAVR Growth'
October 25, 2017 12:36 PM EDTBarclays lowered its price target on Edwards Lifesciences (NYSE: EW) to $118.00 (from $120.00) while maintaining a Equalweight rating, following the company's third quarter earnings report.
Analyst Matthew Taylor notes the company delivered third quarter earnings per share and revenue results below consensus projections, as... More
Edwards Lifesciences (EW) PT Lowered to $135 at Canaccord Genuity
October 25, 2017 5:33 AM EDTCanaccord Genuity lowered its price target on Edwards Lifesciences (NYSE: EW) to $135.00 (from $155.00) while maintaining a Buy rating.
Analyst Jason Mills remains positive on the stock noting LT TAVR & TMVR catalyst trump the negative NT trends and would be a buyer on weakness in the $100 range.
... More